Novagali, Santen Pharmaceuticals Co. Ltd. deal

Santen acquired a 50.55% stake in Novagali for €6.15 per share through the purchase of 8.2 million shares for a total of €50.7 million ($68.6 million) from a group of shareholders that includes funds ...